PeptiDream Inc.
Discovery of innovative peptide medicines leveraging its proprietary Peptide Discovery Platform System
PeptiDream is leading the translation of macrocyclic peptides into a whole new class of innovative medicines to address unmet medical needs and improve the quality of life of patients worldwide. Leveraging its proprietary Peptide Discovery Platform System (PDPS®) technology, we aim to discover and develop a broad and diverse pipeline of peptide therapeutics. In its radiopharmaceutical business, PeptiDream group markets and sells a number of approved radiopharmaceuticals in Japan through its wholly-owned subsidiary PDRadiopharma.
Drug Discovery/Drug Discovery Support
- Pharmaceuticals
